Singapore markets open in 4 hours 23 minutes
Straits Times Index
3,292.93 -3.96 (-0.12%) S&P 500
5,127.79 +63.59 (+1.26%) Dow
38,675.68 +449.98 (+1.18%) Nasdaq
16,156.33 +315.33 (+1.99%) Bitcoin USD
63,694.81 -251.50 (-0.39%) CMC Crypto 200
1,326.53 +49.55 (+3.88%)
Crinetics Pharmaceuticals, Inc. (CRNX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 46.78 |
| Open | 47.52 |
| Bid | 47.13 x 200 |
| Ask | 47.23 x 200 |
| Day's range | 47.13 - 48.37 |
| 52-week range | 15.76 - 49.58 |
| Volume | |
| Avg. volume | 817,890 |
| Market cap | 3.717B |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Jeff Knight, the Chief Operating Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), has sold 32,359 shares of the company on March 22, 2024, according to a recent SEC filing.
- GuruFocus.com
Insider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...
Chief Medical and Development Officer Dana Pizzuti of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 15,089 shares of the company on March 20, 2024, according to a recent SEC filing.
- GuruFocus.com
Director Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Director Matthew Fust has sold 60,000 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) on March 20, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.